AAAAAA
Results:
1-25
|
Results: 25
Authors:
PACE A
BOVE L
ALOE A
NARDI M
PIETRANGELI A
CALABRESI F
INNOCENTI P
JANDOLO B
Citation: A. Pace et al., PACLITAXEL NEUROTOXICITY - CLINICAL AND NEUROPHYSIOLOGICAL STUDY OF 23 PATIENTS, Italian journal of neurological sciences, 18(2), 1997, pp. 73-79
Authors:
NARDI M
ALOE A
DEMARCO S
COGNETTI F
IACOVELLI A
ATLANTE G
CALABRESI F
Citation: M. Nardi et al., PACLITAXEL AS SALVAGE THERAPY IN ADVANCED PRETREATED OVARIAN-CANCER -A PHASE-II STUDY, American journal of clinical oncology, 20(3), 1997, pp. 230-232
Authors:
POLLERA CF
CERIBELLI A
CRECCO M
OLIVA C
CALABRESI F
Citation: Cf. Pollera et al., PROLONGED INFUSION GEMCITABINE - A CLINICAL-PHASE-I STUDY AT LOW (300MG M(2)) AND HIGH-DOSE (875 MG/M(2)) LEVELS/, Investigational new drugs, 15(2), 1997, pp. 115-121
Authors:
CONTE PF
LATREILLE J
MAURIAC L
CALABRESI F
SANTOS R
CAMPOS D
BONNETERRE J
FRANCINI G
FORD JM
Citation: Pf. Conte et al., DELAY IN PROGRESSION OF BONE METASTASES IN BREAST-CANCER PATIENTS TREATED WITH INTRAVENOUS PAMIDRONATE - RESULTS FROM A MULTINATIONAL RANDOMIZED CONTROLLED TRIAL, Journal of clinical oncology, 14(9), 1996, pp. 2552-2559
Authors:
MARTELLI M
VIGNETTI M
ZINZANI PL
GHERLINZONI F
MELONI G
FIACCHINI M
DESANCTIS V
PAPA G
MARTELLI MF
CALABRESI F
TURA S
MANDELLI F
Citation: M. Martelli et al., HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS DEXAMETHASONE, CISPLATIN, AND CYTARABINE IN AGGRESSIVE NON-HODGKINS-LYMPHOMA WITH PARTIAL-RESPONSE TO FRONT-LINE CHEMOTHERAPY - A PROSPECTIVE RANDOMIZED ITALIAN MULTICENTER STUDY, Journal of clinical oncology, 14(2), 1996, pp. 534-542
Authors:
NARDI M
DELLAGIULIA M
POLLERA CF
MAROLLA P
RUGGERI EM
IACOVELLI A
ATLANTE G
CALABRESI F
Citation: M. Nardi et al., A COMBINATION OF IFOSFAMIDE AND MITOXANTRONE AS SALVAGE THERAPY IN PATIENTS WITH ADVANCED OVARIAN-CANCER, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 298-301
Authors:
MAZZA P
ZINZANI PL
MARTELLI M
FIACCHINI M
BOCCHIA M
PILERI S
FALINI B
MARTELLI MF
AMADORI S
PAPA G
CANTONETTI M
LUCARELLI G
MORETTI L
CALABRESI F
RUGGERI E
GHERLINZONI F
BENDANDI M
GUGLIELMI C
BURGIO V
DAMMACCO F
LAUTA VM
LIBERATI AM
MANDELLI F
TURA S
Citation: P. Mazza et al., MACOP-B VS F-MACHOP REGIMEN IN THE TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS, Leukemia & lymphoma, 16(5-6), 1995, pp. 457-463
Authors:
GAMUCCI T
CALABRESI F
ZEULI M
CERIBELLI A
COLUCCI G
LOMEO A
MALUTA S
BATTELLI T
BIANCO R
BREMA F
GHEZZI P
MAJOLI I
Citation: T. Gamucci et al., PREVENTION OF ANEMIA IN CANCER-PATIENTS TREATED WITH CISPLATIN-CONTAINING CHEMOTHERAPY, European journal of cancer, 31A, 1995, pp. 239-239
Authors:
PERETZ T
SULKES A
CHOLLET P
GELMON K
PARIDAENS R
GORBONUVA V
CATIMEL G
KUHNLE H
HUININK WTB
KHAYAT D
DITTRICH C
KLAASSEN U
BERGH J
WILKING N
NABHOLTZ JM
CALABRESI F
TUBIANAHULIN M
CHAZARD M
GALLANT G
DIERGARTEN K
WESTBERG R
BOGAERT J
RENARD J
WEIL C
Citation: T. Peretz et al., A MULTICENTER, RANDOMIZED STUDY OF 2 SCHEDULES OF PACLITAXEL (PTX) INPATIENTS WITH ADVANCED BREAST-CANCER (ABC), European journal of cancer, 31A, 1995, pp. 345-345
Authors:
PARIDAENS R
BRUNING P
CALABRESI F
AWADA A
ROY JA
KUSENDA Z
PICCART M
Citation: R. Paridaens et al., TAXOL OR DOXORUBICIN AS FIRST LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER (ABC) - A PROSPECTIVE RANDOMIZED PHASE-II STUDY WITH CROSSOVER, European journal of cancer, 31A, 1995, pp. 346-346
Authors:
MAURIAC L
CARRION RP
ALBEROLA V
CALABRESI F
MICHEL RT
SANTOS R
WEHRLE E
ROYCE CM
Citation: L. Mauriac et al., RANDOMIZED TRIAL BETWEEN SELECTIVE AROMATASE INHIBITOR FORMESTANE ((R)LENTARON) VS TAMOXIFEN AS FIRST-LINE HORMONAL-THERAPY IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - CONFIRMATION OF BIOEQUIVALENCE IN SURVIVAL, European journal of cancer, 31A, 1995, pp. 365-365
Authors:
CALABRESI F
GAMUCCI T
Citation: F. Calabresi et T. Gamucci, BIOLOGICAL RESPONSE MODIFIERS, Lung cancer, 12, 1995, pp. 193-198
Authors:
KRUIT WHJ
GOEY SH
CALABRESI F
LINDEMANN A
STAHEL RA
POLIWODA H
OSTERWALDER B
STOTER G
Citation: Whj. Kruit et al., FINAL REPORT OF A PHASE-II STUDY OF INTERLEUKIN-2 AND INTERFERON ALPHA IN PATIENTS WITH METASTATIC MELANOMA, British Journal of Cancer, 71(6), 1995, pp. 1319-1321
Authors:
CALABRESI F
MAROLLA P
DILAURO L
CURCIO CG
PAOLETTI G
LOMBARDI A
GIANNARELLI D
BALLATORE P
FOGGI CM
DIPALMA M
STOLFI R
CORTESI E
Citation: F. Calabresi et al., LONIDAMINE AS A POTENTIATING AGENT OF THE FAC REGIMEN IN THE TREATMENT OF ADVANCED BREAST-CANCER - RESULTS OF A MULTICENTRIC RANDOMIZED CLINICAL-STUDY, International journal of oncology, 4, 1994, pp. 753-760
Authors:
FALCONE A
PFANNER E
RICCI S
BERTUCCELLI M
CIANCI C
CARRAI M
DEMARCO S
CERIBELLI A
BARDUAGNI M
CALABRESI F
COMELLA G
SARCINA R
LORUSSO V
STAMPINO CG
PANDOLFI A
BRUZZI P
CONTE PF
Citation: A. Falcone et al., ORAL DOXIFLURIDINE IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL-CANCER - A MULTICENTER PHASE-II STUDY, Annals of oncology, 5(8), 1994, pp. 760-762
Authors:
VERWEIJ J
WANDERS J
NIELSEN AL
PAVLIDIS N
CALABRESI F
HUININK WT
BRUNTSCH U
PICCART M
FRANKLIN H
KAYE SB
Citation: J. Verweij et al., PHASE-II STUDIES OF ELSAMITRUCIN IN BREAST-CANCER, COLORECTAL-CANCER,NONSMALL CELL LUNG-CANCER AND OVARIAN-CANCER, Annals of oncology, 5(4), 1994, pp. 375-376
Authors:
POLLERA CF
CERIBELLI A
CRECCO M
CALABRESI F
Citation: Cf. Pollera et al., WEEKLY GEMCITABINE IN ADVANCED BLADDER-CANCER - A PRELIMINARY-REPORT FROM A PHASE-I STUDY, Annals of oncology, 5(2), 1994, pp. 182-184
Authors:
POLLERA CF
CALABRESI F
MORESCHI M
RUGGERI EM
GIANNARELLI D
MASCIULLI R
TESTA U
PESCHLE C
Citation: Cf. Pollera et al., HIGH DOSE-INTENSE CHEMOTHERAPY ALONE OR IN COMBINATION WITH INTERLEUKIN-2 FOR SMALL-CELL LUNG-CANCER - A PILOT-STUDY, Cancer investigation, 12(6), 1994, pp. 574-587
Authors:
POLLERA CF
CERIBELLI A
CRECCO M
CALABRESI F
Citation: Cf. Pollera et al., WEEKLY GEMCITABINE IN ADVANCED OR METASTATIC SOLID TUMORS - A CLINICAL-PHASE-I STUDY, Investigational new drugs, 12(2), 1994, pp. 111-119
Authors:
GHERLINZONI F
MARTELLI M
MAZZA P
ZINZANI PL
PILERI S
BOCCHIA M
MELONI G
VIGNETTI M
GUGLIELMI C
AMADORI S
ANTIMI M
BURGIO VL
MARTELLI MF
FALINI B
LIBERATI AM
BENDANDI M
MIGGIANO MC
CALABRESI F
DAMMACCO F
LUCARELLI G
MORETTI L
MANDELLI F
TURA S
Citation: F. Gherlinzoni et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) VS DHAP IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS (NHL) PARTIALLY RESPONDING TO 1ST LINE CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000234-10000234
Authors:
BAJETTA E
COLLEONI M
ROSSO R
SOBRERO A
AMADORI D
COMELLA G
MARANGOLO M
SCANNI A
LORUSSO V
CALABRESI F
BONSIGNORI M
CRIVELLARI D
PASQUINI E
BRUZZI P
REPETTO M
CRISCUOLO D
Citation: E. Bajetta et al., PROSPECTIVE RANDOMIZED TRIAL COMPARING FLUOROURACIL VERSUS DOXIFLURIDINE FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER, European journal of cancer, 29A(12), 1993, pp. 1658-1663
Authors:
BOCCI V
CARRARO F
ZEULI M
NALDINI A
CALABRESI F
Citation: V. Bocci et al., THE LYMPHATIC ROUTE .8. DISTRIBUTION AND PLASMA-CLEARANCE OF RECOMBINANT HUMAN INTERLEUKIN-2 AFTER SC ADMINISTRATION WITH ALBUMIN IN PATIENTS (VOL 6, PG 73, 1993), Biotherapy, 6(3), 1993, pp. 233-233
Authors:
BOCCI V
CARRARO F
ZEULI M
NALDINI A
CALABRESI F
Citation: V. Bocci et al., THE LYMPHATIC ROUTE .8. DISTRIBUTION AND PLASMA-CLEARANCE OF RECOMBINANT HUMAN INTERLEUKIN-2 AFTER SC ADMINISTRATION WITH ALBUMIN IN PATIENTS, Biotherapy, 6(1), 1993, pp. 73-77
Authors:
ZINZANI PL
TURA S
PAPA G
FANIN R
MARTELLI MF
GALIENI P
LEONE G
CHISESI T
LISO V
DAMMACCO F
ROTOLI B
MORETTI L
CUNEO A
VOLPE E
GOBBI M
CAJOZZO A
CALABRESI F
MANDELLI F
Citation: Pl. Zinzani et al., THE ROLE OF RHGM-CSF IN THE CONVENTIONAL POLYCHEMOTHERAPY OF HIGH-GRADE NON-HODGKINS-LYMPHOMA, Journal of cellular biochemistry, 1993, pp. 271-271
Authors:
STERNBERG CN
ARENA MG
CALABRESI F
DECARLI P
PLATANIA A
ZEULI M
GIANNARELLI D
CANCRINI A
PANSADORO V
Citation: Cn. Sternberg et al., NEOADJUVANT M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN) FOR INFILTRATING TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, Cancer, 72(6), 1993, pp. 1975-1982
Risultati:
1-25
|